Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


04.12.2017

2 Ann Intern Med
2 Arch Gynecol Obstet
1 Asian Pac J Cancer Prev
1 Biol Chem
1 Biomed Pharmacother
1 BMJ
1 Brachytherapy
2 Cancer Med
1 Cell Biochem Funct
1 Comput Math Methods Med
1 Contemp Oncol (Pozn)
1 Eur J Oncol Nurs
1 Eur J Public Health
1 Front Microbiol
5 Gynecol Oncol
1 IEEE J Biomed Health Inform
1 Indian J Med Microbiol
1 Int J Biochem Cell Biol
1 Int J Cancer
1 Int J Environ Res Public Health
1 Int J Gynecol Cancer
1 J Acquir Immune Defic Syndr
1 J Adolesc Health
1 J Cancer Res Clin Oncol
5 J Gynecol Oncol
1 J Med Screen
1 J Nat Med
1 J Pediatr Adolesc Gynecol
1 J Radiat Res
1 Medicine (Baltimore)
1 Mol Clin Oncol
1 Nucl Med Commun
1 Obstet Gynecol Sci
1 Oncogene
2 Oncol Lett
1 Oncotarget
1 Papillomavirus Res
1 Pediatrics
2 PLoS One
1 Prev Chronic Dis
2 Prev Med
1 Prev Med Rep
1 Rev Peru Med Exp Salud Publica
1 Rinsho Ketsueki
3 Sci Rep
1 Science
1 Swiss Med Wkly
1 Womens Health Issues
2 Zhonghua Fu Chan Ke Za Zhi
1 Zhonghua Yi Xue Yi Chuan Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. RONCO G, Franceschi S
    Cervical Cancer Screening: The Transformational Role of Routine Human Papillomavirus Testing.
    Ann Intern Med. 2017 Nov 28. pii: 2664378. doi: 10.7326/M17-2872.
    PubMed     Text format    

  2. CASTLE PE, Kinney WK, Xue X, Cheung LC, et al
    Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.
    Ann Intern Med. 2017 Nov 28. pii: 2664574. doi: 10.7326/M17-1609.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  3. ZHANG Z, Wang J, Wang X, Song W, et al
    MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
    Arch Gynecol Obstet. 2017 Nov 24. pii: 10.1007/s00404-017-4598.
    PubMed     Text format     Abstract available

  4. MA C, Zhang Y, Li R, Mao H, et al
    Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis.
    Arch Gynecol Obstet. 2017 Nov 24. pii: 10.1007/s00404-017-4597.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  5. SHARMA M, Khan R, Aggarwal M, Sharma A, et al
    Modulatory Effects of Chemoradiation on Angiogenic Factors and Laminin in Cervical Cancer: Link with Treatment Response
    Asian Pac J Cancer Prev. 2017;18:2937-2944.
    PubMed     Text format     Abstract available


    Biol Chem

  6. MENG Y, Li Q, Li L, Ma R, et al
    The long non-coding RNA CRNDE promotes cervical cancer cell growth and metastasis.
    Biol Chem. 2017;399:93-100.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  7. HAN SZ, Liu HX, Yang LQ, Cui LD, et al
    Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-kappaB.
    Biomed Pharmacother. 2017 Nov 20. pii: S0753-3322(17)30825.
    PubMed     Text format     Abstract available


    BMJ

  8. BARRETT J
    Gender dysphoria: assessment and management for non-specialists.
    BMJ. 2017;357:j2866.
    PubMed     Text format    


    Brachytherapy

  9. VAN HEERDEN LE, van Wieringen N, Koedooder K, Rasch CRN, et al
    Dose warping uncertainties for the accumulated rectal wall dose in cervical cancer brachytherapy.
    Brachytherapy. 2017 Nov 22. pii: S1538-4721(17)30477.
    PubMed     Text format     Abstract available


    Cancer Med

  10. ZHANG W, Liu K, Ye B, Liang W, et al
    Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.
    Cancer Med. 2017 Nov 28. doi: 10.1002/cam4.1270.
    PubMed     Text format     Abstract available

  11. VAN DER HORST J, Siebers AG, Bulten J, Massuger LF, et al
    Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
    Cancer Med. 2017;6:416-423.
    PubMed     Text format     Abstract available


    Cell Biochem Funct

  12. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Cell Biochem Funct. 2017;35:464-471.
    PubMed     Text format     Abstract available


    Comput Math Methods Med

  13. GUTIERREZ-FRAGOSO K, Acosta-Mesa HG, Cruz-Ramirez N, Hernandez-Jimenez R, et al
    Optimization of Classification Strategies of Acetowhite Temporal Patterns towards Improving Diagnostic Performance of Colposcopy.
    Comput Math Methods Med. 2017;2017:5989105.
    PubMed     Text format     Abstract available


    Contemp Oncol (Pozn)

  14. HUSSAIN S
    Comparative efficacy of epigallocatechin-3-gallate against H2O2-induced ROS in cervical cancer biopsies and HeLa cell lines.
    Contemp Oncol (Pozn). 2017;21:209-212.
    PubMed     Text format     Abstract available


    Eur J Oncol Nurs

  15. ANAMAN-TORGBOR JA, King J, Correa-Velez I
    Barriers and facilitators of cervical cancer screening practices among African immigrant women living in Brisbane, Australia.
    Eur J Oncol Nurs. 2017;31:22-29.
    PubMed     Text format     Abstract available


    Eur J Public Health

  16. PEDERSEN K, Burger EA, Campbell S, Nygard M, et al
    Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metric.
    Eur J Public Health. 2017;27:1089-1094.
    PubMed     Text format     Abstract available


    Front Microbiol

  17. HAVERKOS HW, Haverkos GP, O'Mara M
    Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer.
    Front Microbiol. 2017;8:2253.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  18. PEI X, Xiang L, Ye S, He T, et al
    Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;147:589-596.
    PubMed     Text format     Abstract available

  19. DEL CARMEN MG, Rice LW
    International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Gynecol Oncol. 2016 Nov 12. pii: S0090-8258(16)31572.
    PubMed     Text format    

  20. LIAO JB
    Immunotherapy for Gynecologic Cancers: State of the Science.
    Gynecol Oncol. 2016 May 27. pii: S0090-8258(16)30758.
    PubMed     Text format    

  21. PHILP L, Covens A, Vicus D, Kupets R, et al
    Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer.
    Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31350.
    PubMed     Text format     Abstract available

  22. CHEN BJ, Byrne FL, Takenaka K, Modesitt SC, et al
    Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer.
    Gynecol Oncol. 2017 Oct 16. pii: S0090-8258(17)31367.
    PubMed     Text format     Abstract available


    IEEE J Biomed Health Inform

  23. LU Z, Carneiro G, Bradley AP, Ushizima D, et al
    Evaluation of Three Algorithms for the Segmentation of Overlapping Cervical Cells.
    IEEE J Biomed Health Inform. 2017;21:441-450.
    PubMed     Text format     Abstract available


    Indian J Med Microbiol

  24. LALL M, Kumar P, Choudhary A, Dar L, et al
    Oncogenic human papillomavirus types in a high risk population.
    Indian J Med Microbiol. 2017;35:316.
    PubMed     Text format    


    Int J Biochem Cell Biol

  25. YU X, Xia J, Li Y, Cao Y, et al
    Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway.
    Int J Biochem Cell Biol. 2017 Nov 23. pii: S1357-2725(17)30300.
    PubMed     Text format     Abstract available


    Int J Cancer

  26. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  27. ROIK EE, Nieboer E, Kharkova OA, Grjibovski AM, et al
    Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.
    Int J Environ Res Public Health. 2017;14.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  28. KIM H, Kim YS, Joo JH, Eom KY, et al
    Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).
    Int J Gynecol Cancer. 2017 Nov 17. doi: 10.1097/IGC.0000000000001155.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  29. FIRNHABER C, Swarts A, Goeieman B, Rakhombe N, et al
    Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001539.
    PubMed     Text format     Abstract available


    J Adolesc Health

  30. FOXX AM, Zhu Y, Mitchel E, Nikpay S, et al
    Cervical Cancer Screening and Follow-Up Procedures in Women Age <21 Years Following New Screening Guidelines.
    J Adolesc Health. 2017 Nov 22. pii: S1054-139X(17)30467.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  31. MARTINEZ-CAMPOS C, Bahena-Roman M, Torres-Poveda K, Burguete-Garcia AI, et al
    TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
    J Cancer Res Clin Oncol. 2017;143:2437-2445.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  32. SUGIYAMA T, Takeuchi S, Itamochi H
    Surgical management of non-invasive uterine clear cell carcinoma.
    J Gynecol Oncol. 2017;28:e55.
    PubMed     Text format    

  33. MATSUO K, Grubbs BH, Mikami M
    Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer.
    J Gynecol Oncol. 2018;29:e10.
    PubMed     Text format    

  34. LEE KB, Kim YS, Lee JM
    Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients.
    J Gynecol Oncol. 2018;29:e5.
    PubMed     Text format     Abstract available

  35. JIANG W, Xiang L, Pei X, He T, et al
    Mutational analysis of KRAS and its clinical implications in cervical cancer patients.
    J Gynecol Oncol. 2018;29:e4.
    PubMed     Text format     Abstract available

  36. MATSUO K, Shimada M, Saito T, Takehara K, et al
    Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.
    J Gynecol Oncol. 2018;29:e11.
    PubMed     Text format     Abstract available


    J Med Screen

  37. LIM AW, Hollingworth A, Kalwij S, Curran G, et al
    Offering self-sampling to cervical screening non-attenders in primary care.
    J Med Screen. 2017;24:43-49.
    PubMed     Text format     Abstract available


    J Nat Med

  38. KUMAGAI K, Tsuda M, Fukushi E, Kawabata J, et al
    Iriomoteolides-9a and 11a: two new odd-numbered macrolides from the marine dinoflagellate Amphidinium species.
    J Nat Med. 2017;71:506-512.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  39. SHINNICK JK, Kumar N, Beffa L, Miller K, et al
    Management of Low-Grade Cervical Mullerian Adenosarcoma in a 14-Year-Old Girl.
    J Pediatr Adolesc Gynecol. 2017;30:652-654.
    PubMed     Text format     Abstract available


    J Radiat Res

  40. KUSADA T, Toita T, Ariga T, Maemoto H, et al
    Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
    J Radiat Res. 2017 Nov 23:1-10. doi: 10.1093.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  41. MAO Q, Luo J, Fang J, Jiang H, et al
    Management of radiation-induced rectovesical fistula in a woman using ileum: A case report and review of the literature.
    Medicine (Baltimore). 2017;96:e8553.
    PubMed     Text format     Abstract available


    Mol Clin Oncol

  42. HOELLEN F, Waldmann A, Banz-Jansen C, Holtrich U, et al
    Claudin-1 expression in cervical cancer.
    Mol Clin Oncol. 2017;7:880-884.
    PubMed     Text format     Abstract available


    Nucl Med Commun

  43. ZHOU Z, Liu X, Hu K, Zhang F, et al
    The clinical value of PET and PET/CT in the diagnosis and management of suspected cervical cancer recurrence.
    Nucl Med Commun. 2017 Nov 20. doi: 10.1097/MNM.0000000000000775.
    PubMed     Text format     Abstract available


    Obstet Gynecol Sci

  44. JANG TK, Shin SJ, Chung H, Kwon SH, et al
    A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy.
    Obstet Gynecol Sci. 2017;60:549-557.
    PubMed     Text format     Abstract available


    Oncogene

  45. ZHONG Y, Yang J, Xu WW, Wang Y, et al
    KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
    Oncogene. 2017;36:6177-6189.
    PubMed     Text format     Abstract available


    Oncol Lett

  46. DENG H, Deng Y, Liu F, Chen J, et al
    Stomatin-like protein 2 is overexpressed in cervical cancer and involved in tumor cell apoptosis.
    Oncol Lett. 2017;14:6355-6364.
    PubMed     Text format     Abstract available

  47. YANG MC, Chien ST, Yang TF, Lin SY, et al
    Downregulation of nuclear and cytoplasmic Chibby is associated with advanced cervical cancer.
    Oncol Lett. 2017;14:6632-6644.
    PubMed     Text format     Abstract available


    Oncotarget

  48. MENG J, Zhu L, Zhu L, Xie L, et al
    Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT.
    Oncotarget. 2017;8:92442-92453.
    PubMed     Text format     Abstract available


    Papillomavirus Res

  49. LI M, Nyabigambo A, Navvuga P, Nuwamanya E, et al
    Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda.
    Papillomavirus Res. 2017;4:17-21.
    PubMed     Text format     Abstract available


    Pediatrics

  50. TROISI R, Hatch EE, Titus L
    The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy.
    Pediatrics. 2016;138.
    PubMed     Text format    


    PLoS One

  51. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    PubMed     Text format     Abstract available

  52. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    PubMed     Text format     Abstract available


    Prev Chronic Dis

  53. STEELE CB, Townsend JS, Courtney-Long EA, Young M, et al
    Prevalence of Cancer Screening Among Adults With Disabilities, United States, 2013.
    Prev Chronic Dis. 2017;14:E09.
    PubMed     Text format     Abstract available


    Prev Med

  54. KLING JM, Vegunta S, Al-Badri M, Faubion SS, et al
    Routine pelvic examinations: A descriptive cross-sectional survey of women's attitudes and beliefs after new guidelines.
    Prev Med. 2017;94:60-64.
    PubMed     Text format     Abstract available

  55. SUBA EJ, Zarka MA, Raab SS
    Human papillomavirus screening for low and middle-income countries.
    Prev Med. 2017;100:296.
    PubMed     Text format    


    Prev Med Rep

  56. HOOI DJ, Meijer CJLM, Witte BI, Bravio IG, et al
    Supravaginal hysterectomy in Curacao prevalence and impact on screening for cervical cancer.
    Prev Med Rep. 2017;8:238-241.
    PubMed     Text format     Abstract available


    Rev Peru Med Exp Salud Publica

  57. RUIZ R, Serrano M, Ruiz EF, Mantilla R, et al
    [Clinical-pathological features and survival in young women with cervical cancer: a retrospective analysis from the instituto nacional de enfermedades neoplasicas].
    Rev Peru Med Exp Salud Publica. 2017;34:218-227.
    PubMed     Text format     Abstract available


    Rinsho Ketsueki

  58. MUTOH T, Takatsuki H, Mannoji K, Kawamura K, et al
    Regression of uterine cervical diffuse large B-cell lymphoma transformed from mucosa-associated lymphoid tissue lymphoma subsequent to Chlamydia trachomatis eradication.
    Rinsho Ketsueki. 2017;58:912-916.
    PubMed     Text format     Abstract available


    Sci Rep

  59. LI X, Tian R, Gao H, Yang Y, et al
    Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Sci Rep. 2017;7:16495.
    PubMed     Text format     Abstract available

  60. GOTO M, Osada S, Imagawa M, Nishizuka M, et al
    FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-beta-mediated EMT in cervical cancer cells.
    Sci Rep. 2017;7:16365.
    PubMed     Text format     Abstract available

  61. LIU Z, Liang H, Wang X, Yang H, et al
    Comparison of graphical optimization or IPSA for improving brachytheraphy plans associated with inadequate target coverage for cervical cancer.
    Sci Rep. 2017;7:16423.
    PubMed     Text format     Abstract available


    Science

  62. STEVANOVIC S, Pasetto A, Helman SR, Gartner JJ, et al
    Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
    Science. 2017;356:200-205.
    PubMed     Text format     Abstract available


    Swiss Med Wkly

  63. VASSILAKOS P, Tran PL, Sahli R, Low N, et al
    HPV-negative CIN3 and cervical cancer in Switzerland: any evidence of impact on screening policies?
    Swiss Med Wkly. 2017;147:w14559.
    PubMed     Text format    


    Womens Health Issues

  64. TAVASOLI SM, Kane E, Chiarelli AM, Kupets R, et al
    Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
    Womens Health Issues. 2017 Nov 23. pii: S1049-3867(17)30348.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  65. XUE FX, Shen DH
    [Challenges and strategies in cervical cancer screening and management of cervical lesions].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:730-733.
    PubMed     Text format    

  66. HUANG AJ, Zhao Y, Zou XL, Yan J, et al
    [Study on clinical management of HPV(+)/Pap(-) during cervical cancer screening].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:745-750.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Yi Chuan Xue Za Zhi

  67. ZHANG X, Yan Z, Shi L, Yang H, et al
    [Association of HSPA1A gene single nucleotide polymorphisms with the development of cervical cancer among ethnic Han Chinese from Yunnan].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017;34:909-914.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: